$106 | SAVE $19 | Single User
$213 | SAVE $37 | Site License
$319 | SAVE $56 | Global License

Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 11 Dec 2019 | 239404 | In Stock
Related Topics: FDA

Introduction

Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Noven Pharmaceuticals Inc (Noven), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co Inc, is a specialty pharmaceutical company with focus on the research, development, manufacture, marketing and sale of prescription pharmaceutical products. It advances patient care through transdermal drug delivery. The company’s commercialized transdermal products include Minivelle (estradiol transdermal system); CombiPatch (estradiol/norethindrone acetate transdermal system); and Daytrana (methylphenidate transdermal system). Noven develops prescription transdermal patches using its proprietary transdermal drug delivery technology in the treatment of women’s diseases and central nervous system (CNS) disorders. Noven is headquartered in Miami, Florida, the US.

Noven Pharmaceuticals Inc Key Recent Developments

Sep 23,2019: Noven announces appointment of Dr. Naruhito Higo as chief executive officer

Apr 25,2018: Noven Announces Successful Resolution of FDA Warning Letter

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents

    List of Tables

    List of Figures

    Section 1 - About the Company

    Noven Pharmaceuticals Inc - Key Facts

    Noven Pharmaceuticals Inc - Key Employees

    Noven Pharmaceuticals Inc - Key Employee Biographies

    Noven Pharmaceuticals Inc - Major Products and Services

    Noven Pharmaceuticals Inc - History

    Noven Pharmaceuticals Inc - Company Statement

    Noven Pharmaceuticals Inc - Locations And Subsidiaries

    Head Office

    Other Locations & Subsidiaries

    Section 2 – Company Analysis

    Company Overview

    Noven Pharmaceuticals Inc - Business Description

    Noven Pharmaceuticals Inc - SWOT Analysis

    SWOT Analysis - Overview

    Noven Pharmaceuticals Inc - Strengths

    Noven Pharmaceuticals Inc - Weaknesses

    Noven Pharmaceuticals Inc - Opportunities

    Noven Pharmaceuticals Inc - Threats

    Noven Pharmaceuticals Inc - Key Competitors

    Section 3 – Company’s Lifesciences Financial Deals and Alliances

    Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

    Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

    Noven Pharmaceuticals Inc, Recent Deals Summary

    Section 4 – Company’s Recent Developments

    Sep 23, 2019: Noven announces appointment of Dr. Naruhito Higo as chief executive officer

    Apr 25, 2018: Noven Announces Successful Resolution of FDA Warning Letter

    Section 5 – Appendix

    Methodology

    About GlobalData

    Contact Us

    Disclaimer

List Of Tables
in Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

Noven Pharmaceuticals Inc, Key Facts

Noven Pharmaceuticals Inc, Key Employees

Noven Pharmaceuticals Inc, Key Employee Biographies

Noven Pharmaceuticals Inc, Major Products and Services

Noven Pharmaceuticals Inc, History

Noven Pharmaceuticals Inc, Other Locations

Noven Pharmaceuticals Inc, Subsidiaries

Noven Pharmaceuticals Inc, Key Competitors

Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Noven Pharmaceuticals Inc, Recent Deals Summary

List Of Figures, Charts and Diagrams
in Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Noven Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Additional Details

Publisher

Global Data

Publisher Information

Reference

239404 |

Number of Pages

26

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance ReportSummaryNoven Pharmaceutical...
28 Aug 2018 by Marketline USD $149 (normally
USD $175)
More Info
SAVE 15% today! Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review
Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the...
28 Feb 2018 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance ReportSummaryNoven Pharmaceutical...
04 Aug 2017 by Marketline USD $149 (normally
USD $175)
More Info
SAVE 15% today! Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review
Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the...
01 Feb 2017 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
SummaryNoven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of com...
26 Dec 2016 by Marketline USD $149 (normally
USD $175)
More Info
SAVE 15% today! Noven Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNoven Pharmaceuticals Inc (Noven), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co I...
28 Nov 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNoven Pharmaceuticals, Inc. (Noven), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNoven Pharmaceuticals, Inc. (Noven), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co...
04 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Noven Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
19 Apr 2016 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Noven Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNoven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company. It undertakes the ...
08 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Noven Pharmaceuticals Inc - Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...